- Coordinator
- Fundacio Institut De Recerca Biomedica (irb Barcelona), Spain
- Runs
- 1 September 2026 to 31 August 2030
- Status
- Running
- EU funding
- €10.0m
- Total cost
- €10.0m
- Partners
- 25 organisations in 8 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101292906
What the project is doing
In the project's own words, from its summary on CORDIS.
MD4SB is an ambitious, multidisciplinary project designed to enable the integration of Molecular Dynamics (MD)-derived data and associated analysis tools into three major European Research Infrastructures (EU-RIs): Instruct-ERIC, ELIXIR, and EU-OPENSCREEN ERIC. Building upon the technological groundwork laid by the MDDB project (HORIZON-INFRA-2022-DEV-01-01), MD4SB seeks to bridge the gap between molecular simulation and a range of complementary disciplines, including structural biology, pharmaceutical sciences, computational sciences, and omics-based research.
By developing a flexible, shared platform tailored to the specific needs of each infrastructure, MD4SB will foster synergy among EU-RIs, expand and diversify their service offerings and strengthen connections between life sciences and AI communities. The platform will be validated through a set of ambitious use cases demonstrating the tangible benefits of the integration. Moreover, the early involvement of major pharmaceutical companies ensures that the developed technology will be rapidly adopted by one of the most active and competitive industrial sectors in Europe.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacio Institut De Recerca Biomedica (irb Barcelona) | Barcelona | Spain | Coordinator |
| Ecole Polytechnique Federale De Lausanne | Lausanne | Switzerland | Participant |
| Masarykova univerzita | Brno | Czechia | Participant |
| Ustav Molekularni Genetiky Av Cr V.v.i. | Praha 4 | Czechia | Participant |
| European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric) | Berlin | Germany | Participant |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| Forschungszentrum Julich GmbH | Julich | Germany | Participant |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Participant |
| Janssen-Cilag GmbH | Neuss | Germany | Associatedpartner |
| Johann Wolfgang Goethe-Universitaet Frankfurt Am Main | Frankfurt Am Main | Germany | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Almirall SA | Barcelona | Spain | Associatedpartner |
| Barcelona Supercomputing Center Centro Nacional De Supercomputacion | Barcelona | Spain | Participant |
| Nostrum Biodiscovery SL | Barcelona | Spain | Participant |
| Universidad De Santiago De Compostela | Santiago De Compostela | Spain | Participant |
| Sanofi-Aventis Recherche & Developpement | Gentilly | France | Associatedpartner |
| Cineca Consorzio Interuniversitario | Casalecchio Di Reno Bo | Italy | Participant |
| Consorzio Interuniversitario Risonanze Magnetiche Di Metallo Proteine | Firenze | Italy | Participant |
| Universita Degli Studi Di Firenze | Florence | Italy | Third party |
| Astrazeneca AB | Sodertaelje | Sweden | Associatedpartner |
| Kungliga Tekniska Hoegskolan | Stockholm | Sweden | Participant |
| Linkopings Universitet | Linkoping | Sweden | Associatedpartner |
| Instruct-Eric | Oxford | United Kingdom | Participant |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI